fbpx Treatment | Page 4 | NDARC - National Drug and Alcohol Research Centre


Randomised double-blind placebo-controlled study of lisdexamfetamine for the treatment of methamphetamine dependence

image - Lisdexamfetamine

This randomised double-blind placebo-controlled study, led by St Vincent's Hospital Sydney, aims to examine the safety and efficacy of lisdexamfetamine in the treatment of adults with severe methamphetamine (MA) dependence.

Project Status: